Shares of Tilray Brands, Inc. (NASDAQ:TLRY – Get Free Report) were down 8% during trading on Thursday. The stock traded as low as $2.04 and last traded at $2.07. Approximately 7,722,220 shares were traded during trading, an increase of 80% from the average session volume of 4,296,544 shares. The stock had previously closed at $2.25.
Analysts Set New Price Targets
Several analysts have recently weighed in on TLRY shares. TD lowered their price objective on shares of Tilray Brands from $4.70 to $4.50 and set a “buy” rating for the company in a research note on Monday, October 5th. Wall Street Zen lowered shares of Tilray Brands from a “hold” rating to a “sell” rating in a research note on Saturday, August 1st. Weiss Ratings cut shares of Tilray Brands from a “sell (d-)” rating to a “sell (e+)” rating in a report on Friday, October 23rd. Canaccord Genuity Group decreased their price target on shares of Tilray Brands from $4.50 to $4.00 and set a “hold” rating for the company in a research note on Friday, October 9th. Finally, Zacks Research lowered shares of Tilray Brands from a “hold” rating to a “strong sell” rating in a report on Tuesday, September 29th. One investment analyst has rated the stock with a Strong Buy rating, three have issued a Buy rating, two have issued a Hold rating and two have issued a Sell rating to the company’s stock. According to data from MarketBeat, the company presently has a consensus rating of “Hold” and an average price target of $5.90.
View Our Latest Research Report on TLRY
Tilray Brands Stock Performance
The stock has a market cap of $305.93 million, a P/E ratio of -1.48 and a beta of 2.04. The company has a fifty day moving average price of $3.28 and a 200 day moving average price of $5.11. The company has a debt-to-equity ratio of 0.17, a current ratio of 1.88 and a quick ratio of 1.11.
Tilray Brands (NASDAQ:TLRY – Get Free Report) last issued its earnings results on Thursday, October 8th. The company reported ($0.02) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.18) by $0.16. Tilray Brands had a negative return on equity of 10.39% and a negative net margin of 16.91%. The company had revenue of $257.15 million for the quarter, compared to analysts’ expectations of $266.26 million. On average, equities analysts expect that Tilray Brands, Inc. will post -0.52 EPS for the current year.
Institutional Inflows and Outflows
A number of hedge funds have recently made changes to their positions in the business. Virtu Financial LLC lifted its position in Tilray Brands by 34.4% in the 3rd quarter. Virtu Financial LLC now owns 108,265 shares of the company’s stock valued at $406,000 after acquiring an additional 27,740 shares in the last quarter. Aquatic Capital Management LLC acquired a new position in Tilray Brands during the 3rd quarter valued at about $117,000. Goldman Sachs Group Inc. increased its holdings in Tilray Brands by 68.5% during the 3rd quarter. Goldman Sachs Group Inc. now owns 350,843 shares of the company’s stock worth $1,316,000 after purchasing an additional 142,569 shares in the last quarter. Lighthouse Investment Partners LLC increased its holdings in Tilray Brands by 19.7% during the 3rd quarter. Lighthouse Investment Partners LLC now owns 116,425 shares of the company’s stock worth $437,000 after purchasing an additional 19,146 shares in the last quarter. Finally, Cetera Investment Advisers increased its holdings in Tilray Brands by 37.5% during the 3rd quarter. Cetera Investment Advisers now owns 129,123 shares of the company’s stock worth $484,000 after purchasing an additional 35,228 shares in the last quarter. 9.35% of the stock is currently owned by institutional investors and hedge funds.
Tilray Brands Company Profile
Tilray Brands is a global cannabis and consumer packaged goods company. Its cannabis business produces and sells medical and adult-use products, including dried flower, oils, extracts and edibles, under brands such as Good Supply, Solei, Redecan and Broken Coast. The company serves customers in Canada, the United States and international markets. Its activities include medical cannabis distribution in countries where permitted, as well as cannabis and hemp-related products in North America, subject to local regulations.
Further Reading
- Five stocks we like better than Tilray Brands
- Grand Theft Auto VI Arrives: Why Take-Two Is a Waiting Game
- Greg Abel Makes His Next Moves: Inside Berkshire’s Q3 Portfolio
- Walmart Earnings Change the Narrative as Digital Growth Lifts Outlook
- Whatever Happens to Copper Next, These 3 Investments Offer Different Ways to Play It
Receive News & Ratings for Tilray Brands Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tilray Brands and related companies with MarketBeat.com's FREE daily email newsletter.
